Cargando…

Analysis of genes (TMEM106B, GRN, ABCC9, KCNMB2, and APOE) implicated in risk for LATE-NC and hippocampal sclerosis provides pathogenetic insights: a retrospective genetic association study

Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) is the most prevalent subtype of TDP-43 proteinopathy, affecting up to 1/3rd of aged persons. LATE-NC often co-occurs with hippocampal sclerosis (HS) pathology. It is currently unknown why some individuals with LAT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dugan, Adam J., Nelson, Peter T., Katsumata, Yuriko, Shade, Lincoln M. P., Boehme, Kevin L., Teylan, Merilee A., Cykowski, Matthew D., Mukherjee, Shubhabrata, Kauwe, John S. K., Hohman, Timothy J., Schneider, Julie A., Fardo, David W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442328/ https://www.ncbi.nlm.nih.gov/pubmed/34526147 http://dx.doi.org/10.1186/s40478-021-01250-2

Ejemplares similares

LATE-NC risk alleles (in TMEM106B, GRN, and ABCC9 genes) among persons with African ancestry
por: Katsumata, Yuriko, et al.
Publicado: (2023)

AAV-GRN partially corrects motor deficits and ALS/FTLD-related pathology in Tmem106b(−/−)Grn(−/−) mice
por: Feng, Tuancheng, et al.
Publicado: (2023)

Case report: TMEM106B haplotype alters penetrance of GRN mutation in frontotemporal dementia family
por: Perneel, Jolien, et al.
Publicado: (2023)

TMEM106B reduction does not rescue GRN deficiency in iPSC-derived human microglia and mouse models
por: Dominguez, Sara L., et al.
Publicado: (2023)

Lack of a protective effect of the Tmem106b “protective SNP” in the Grn knockout mouse model for frontotemporal lobar degeneration
por: Cabron, Anne-Sophie, et al.
Publicado: (2023)

Identification of TMEM106B amyloid fibrils provides an updated view of TMEM106B biology in health and disease
por: Perneel, Jolien, et al.
Publicado: (2022)

C-terminal TMEM106B fragments in human brain correlate with disease-associated TMEM106B haplotypes
por: T. Vicente, Cristina, et al.
Publicado: (2023)

Antibody-recognizing residues 188-211 of TMEM106B exhibit immunohistochemical reactivity with the TMEM106B C-terminal fragment
por: Ishikawa, Ruoyi, et al.
Publicado: (2023)

Variation in TMEM106B in chronic traumatic encephalopathy
por: Cherry, Jonathan D., et al.
Publicado: (2018)

Lysosomal dysfunction in TMEM106B hypomyelinating leukodystrophy
por: Ito, Yoko, et al.
Publicado: (2018)

Long noncoding RNA KCNMB2-AS1 acts as an oncogene in ovarian cancer: KCNMB2-AS1 acts as an oncogene in ovarian cancer
por: Cao, Siyu, et al.
Publicado: (2023)

Multiple gene variants linked to Alzheimer’s-type clinical dementia via GWAS are also associated with non-Alzheimer’s neuropathologic entities
por: Katsumata, Yuriko, et al.
Publicado: (2022)

TMEM106A transcriptionally regulated by promoter methylation is involved in invasion and metastasis of hepatocellular carcinoma: TMEM106A is involved in invasion and metastasis of HCC
por: Shi, Shiming, et al.
Publicado: (2022)

The major TMEM106B dementia risk allele affects TMEM106B protein levels and myelin lipid homeostasis in the ageing human hippocampus
por: Lee, Jun Yup, et al.
Publicado: (2023)

In severe ADNC, hippocampi with comorbid LATE-NC and hippocampal sclerosis have substantially more astrocytosis than those with LATE-NC or hippocampal sclerosis alone
por: Niedowicz, Dana M, et al.
Publicado: (2023)

TMEM106B expression is reduced in Alzheimer’s disease brains
por: Satoh, Jun-ichi, et al.
Publicado: (2014)

The major TMEM106B dementia risk allele affects TMEM106B protein levels, fibril formation, and myelin lipid homeostasis in the ageing human hippocampus
por: Lee, Jun Yup, et al.
Publicado: (2023)

TMEM106B aggregation in neurodegenerative diseases: linking genetics to function
por: Jiao, Hai-Shan, et al.
Publicado: (2023)

TMEM106B regulates microglial proliferation and survival in response to demyelination
por: Zhang, Tingting, et al.
Publicado: (2023)

On combining family- and population-based sequencing data
por: Katsumata, Yuriko, et al.
Publicado: (2016)

Quantitative phenotype scan statistic (QPSS) reveals rare variant associations with Alzheimer’s disease endophenotypes
por: Katsumata, Yuriko, et al.
Publicado: (2020)

TMEM106B a Novel Risk Factor for Frontotemporal Lobar Degeneration
por: van der Zee, Julie, et al.
Publicado: (2011)

TMEM106C contributes to the malignant characteristics and poor prognosis of hepatocellular carcinoma
por: Duan, Jicheng, et al.
Publicado: (2021)

TMEM106A inhibits enveloped virus release from cell surface
por: Mao, Dexin, et al.
Publicado: (2022)

Age-dependent formation of TMEM106B amyloid filaments in human brains
por: Schweighauser, Manuel, et al.
Publicado: (2022)

Lysosomal TMEM106B interacts with galactosylceramidase to regulate myelin lipid metabolism
por: Takahashi, Hideyuki, et al.
Publicado: (2023)

The identification of high-performing antibodies for transmembrane protein 106B (TMEM106B) for use in Western blot, immunoprecipitation, and immunofluorescence
por: Ayoubi, Riham, et al.
Publicado: (2023)

The MUC6/AP2A2 Locus and Its Relevance to Alzheimer’s Disease: A Review
por: Nelson, Peter T, et al.
Publicado: (2020)

TMEM106B haplotypes have distinct gene expression patterns in aged brain
por: Ren, Yingxue, et al.
Publicado: (2018)

Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency
por: Arrant, Andrew E., et al.
Publicado: (2018)

A novel, potentially targetable TMEM106B-BRAF fusion in pleomorphic xanthoastrocytoma
por: Hsiao, Susan J., et al.
Publicado: (2017)

Loss of TMEM106B and PGRN leads to severe lysosomal abnormalities and neurodegeneration in mice
por: Feng, Tuancheng, et al.
Publicado: (2020)

Loss of Tmem106b leads to cerebellum Purkinje cell death and motor deficits
por: Rademakers, Rosa, et al.
Publicado: (2021)

Cholesterol activates BK channels by increasing KCNMB1 protein levels in the plasmalemma
por: Bukiya, Anna N., et al.
Publicado: (2021)

TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort
por: van der Zee, Julie, et al.
Publicado: (2011)

Loss of TMEM106B potentiates lysosomal and FTLD‐like pathology in progranulin‐deficient mice
por: Werner, Georg, et al.
Publicado: (2020)

TMEM106B deficiency impairs cerebellar myelination and synaptic integrity with Purkinje cell loss
por: Feng, Tuancheng, et al.
Publicado: (2022)

TMEM106B Acts as a Modifier of Cognitive and Motor Functions in Amyotrophic Lateral Sclerosis
por: Manini, Arianna, et al.
Publicado: (2022)

Generic amyloid fibrillation of TMEM106B in patient with Parkinson’s disease dementia and normal elders
por: Fan, Yun, et al.
Publicado: (2022)

Physical activity in COPD: Minimal clinically important difference for medical events
por: Teylan, Merilee, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4cjpmgtrqvj4s5cqprmlqrs0kr